Latest Options News

Future Battery Minerals Ltd has acquired 100% ownership of the Miriam Project, extinguishing royalties and advancing multiple high-priority gold targets with initial drilling completed. Assay results are expected in early September 2025.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Dalaroo Metals has initiated its maiden field program at the Blue Lagoon zirconium, niobium, and rare earth project in Greenland, aiming to validate historic geochemical anomalies and unlock strategic critical minerals. The work is led by a seasoned Greenland geologist and aligns with growing US interest in diversifying rare earth supply chains.

Podium Minerals has significantly expanded its Parks Reef project with a new Copper-Gold Zone resource, increasing the basket price by 18% and completing a $2.6 million oversubscribed capital raise.

St Barbara Limited updates on its Nova Scotia operations with progress on the 15-Mile Processing Hub prefeasibility study, reclamation milestones at Touquoy, and a pioneering pumped hydro energy storage project, while weighing strategic options for its Atlantic Gold assets.

Deep Yellow Limited reports significant progress at its flagship Tumas uranium project in Namibia and successful pilot testing at Mulga Rock in Australia, supported by a robust cash position of A$217.4 million.

Cyclone Metals reports strong progress on its Iron Bear Project, highlighting a completed renewable energy power study and successful metallurgical test results that underpin its sustainable mining ambitions.

Yari Minerals has significantly expanded its flagship Rolleston South Coal Project resource by 91%, positioning itself strongly in Queensland’s Bowen Basin ahead of a maiden drilling campaign planned for late 2025.

Canadian Phosphate Limited advances its Canadian operations with new bulk sampling permits and a promising exploration target, while steady sales and customer upgrades signal growth ahead.

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.

Mantle Minerals has received conversion notices for over half of its outstanding convertible notes, prompting a shareholder vote in September to decide on converting $742,000 of debt into shares with attached options.

Mantle Minerals has agreed to sell its Mt Roe gold project subsidiary for $13.5 million, marking a pivotal step in its growth strategy. The company also secured a government drilling grant for its Mt Berghaus project and raised $250,000 to support ongoing operations.